Repligen to Report First Quarter 2021 Financial Results
April 20, 2021 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2021 financial results on Tuesday, May 4, 2021....
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
March 17, 2021 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present...
Repligen Corporation to Present at Barclays Global Healthcare Conference
March 03, 2021 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present...
Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
February 24, 2021 07:30 ET
|
Repligen Corporation
Reports quarterly revenue of $108.6 million, representing 56% year-over-year growth, and annual revenue of $366.3 million represents 36% year-over-year growthOrganic revenue growth was 47% for the...
Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference
February 22, 2021 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present...
Repligen to Report Fourth Quarter and Full Year 2020 Financial Results
February 11, 2021 15:00 ET
|
Repligen Corporation
Webcast and Conference Call to Be Held Wednesday, February 24, 2021 at 8:30 a.m. ESTWALTHAM, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the...
Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines
February 08, 2021 07:36 ET
|
Repligen Corporation
WALTHAM, Mass. and HALLE (Saale), Germany, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo...
Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021 13:00 ET
|
Repligen Corporation
WALTHAM, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present...
Repligen Corporation Announces Closing of Public Offering of $312.2 Million, Including Full Exercise of Underwriters’ Option
December 10, 2020 16:18 ET
|
Repligen Corporation
WALTHAM, Mass., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced the closing of its previously announced underwritten public offering of an aggregate of 1.725...
Repligen Corporation Prices Public Offering of Shares of Common Stock
December 07, 2020 21:41 ET
|
Repligen Corporation
WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced the pricing of an underwritten public offering of 1.5 million shares of its common stock at a...